Skip to main content
OpenTrials

Clinical trial condition

Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

210 public trials 82 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma trial results

Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 31 locations
View Trial Details
Recruiting

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

NCT06780111

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • UPMC Hillman Cancer Center ( Site 1904) Pittsburgh, Pennsylvania, United States
  • Liga Norte Riograndense Contra o Cancer ( Site 1301) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceicao ( Site 1300) Porto Alegre, Rio Grande do Sul, Brazil
  • Clínica Puerto Montt ( Site 1406) Port Montt, Los Lagos Region, Chile
View all 45 locations
View Trial Details
Recruiting

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

NCT05319730

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 4905) Los Angeles, California, United States
  • Hematology-Oncology Associates of Central NY, P.C. ( Site 4925) East Syracuse, New York, United States
  • Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 4907) New York, United States
View all 58 locations
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Recruiting

SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma

NCT07700667

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Jilin Cancer Hospital Changchun, China
  • Chengdu Fifth People's Hospital Chengdu, China
  • Sichuan Cancer Hospital & Institute Chengdu, China
  • West China Hospital, Sichuan University Chengdu, China
View all 24 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT06084481

Conditions
Adenocarcinoma, Biliary Tract Cancers, Biliary Tract Diseases, +31 more
Locations
  • City of Hope National Medical Center /ID# 258645 Duarte, California, United States
  • University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128 Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926 Denver, Colorado, United States
  • Florida Cancer Specialists /ID# 261569 Sarasota, Florida, United States
View all 54 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

NCT07554521

Conditions
Advanced Gastroesophageal Adenocarcinoma, Advanced Unresectable Gastric Adenocarcinoma, Carcinoma, +14 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Bioresearch Partners Holding Hialeah Hospital Hialeah, Florida, United States
  • Florida Clinical Trials Group Plantation Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac Tamarac, Florida, United States
View Trial Details
Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

NCT07109726

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +42 more
Locations
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mayo Rochester Rochester, Minnesota, United States
  • Washington Univ. School of Medicine St Louis, Missouri, United States
View all 18 locations
View Trial Details
Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

NCT06644781

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 132 locations
View Trial Details

Related conditions